Clinical outcomes of bevacizumab in combination with paclitaxel/carboplatin compared with paclitaxel/carboplatin alone in previously untreated Japanese patients with advanced non-squamous non-small-cell lung cancer (NSCLC)

被引：2

作者：

Ichinose, Y. ^{[1
]}

Seto, T. ^{[1
]}

Kunitoh, H. ^{[2
]}

Horai, T. ^{[3
]}

Nishiwaki, Y. ^{[4
]}

Hida, T. ^{[5
]}

Yamamoto, N. ^{[6
]}

Kawahara, M. ^{[7
]}

Saijo, N. ^{[8
]}

Fukuoka, M. ^{[8
]}

机构：

[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan

[2] Natl Canc Ctr, Dept Med Oncol, Tokyo, Japan

[3] Canc Inst Hosp, Dept Thorac Med Oncol, Tokyo, Japan

[4] Natl Canc Ctr Hosp E, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[5] Aichi Canc Ctr Hosp, Dept Thorac Oncol, Nagoya, Aichi 464, Japan

[6] Shizuoka Canc Ctr, Thorac Oncol Div, Nagaizumi, Shizuoka, Japan

[7] Natl Hosp Org, Dept Thorac Oncol, Kinki Chuo Chest Med Ctr, Osaka, Japan

[8] Kinki Univ, Sch Med, Dept Med Oncol, Osaka 589, Japan

来源：

EJC SUPPLEMENTS | 2009年 / 7卷 / 02期

关键词：

D O I：

10.1016/S1359-6349(09)71721-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：508 / 508

页数：1